EU international locations can quickly begin vaccinating kids as younger as 5 towards COVID-19 after the European Medicines Company mentioned the BioNTech/Pfizer COVID-19 vaccine was secure and efficient in youthful children.
The EMA’s medicines committee CHMP really useful Thursday that the vaccine is given as two doses three weeks aside to these aged 5 to 11. The dose on this age group is one third of the quantity given to these aged 12 and older, the EMA mentioned.
A research on this age vary confirmed this decrease dose elicited an identical antibody response to these seen in adults aged 16 to 25.
A placebo-controlled research of almost 2,000 kids aged 5 to 11 with no prior coronavirus an infection demonstrated the vaccine was 90.7 p.c efficient at stopping symptomatic COVID-19.
Unintended effects seen within the research have been much like these seen in adults, like injection website soreness and complications and chills.
For the reason that Delta variant has dominated in Europe, an infection charges have soared particularly amongst younger folks. Whereas there are much less prone to expertise extreme sickness, they’re bringing the extremely transmissible virus again into their properties.
In Austria, which has simply gone right into a full lockdown and plans a common vaccine mandate from February, the newest weekly incidence in 5- to 14-year-olds is 2,249 circumstances per 100,000 folks — greater than double the nationwide determine.
The World Well being Group on Wednesday additionally modified tack and supported vaccinating kids, primarily based on native conditions, however mentioned that the worldwide sharing of vaccines ought to come first.
As soon as the EMA’s resolution is rubber stamped by the European Fee, EU international locations will determine if and when to roll out the jab to youthful kids.